16.11.2013 Views

Gas-Chromatographic Assay for Thiopental in ... - Clinical Chemistry

Gas-Chromatographic Assay for Thiopental in ... - Clinical Chemistry

Gas-Chromatographic Assay for Thiopental in ... - Clinical Chemistry

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CLIN.CHEM. 27/1, 113-115 (1981)<br />

<strong>Gas</strong>-<strong>Chromatographic</strong> <strong>Assay</strong> <strong>for</strong> <strong>Thiopental</strong> <strong>in</strong> Plasma, with Use of a<br />

Nitrogen-Specific Detector<br />

Donald Jung, Michael Mayersohn,’ and Donald Perrier<br />

An accurate, sensitive, and specific gas-liquid-chromatographic<br />

procedure is described <strong>for</strong> determ<strong>in</strong><strong>in</strong>g concentrations<br />

of thiopental <strong>in</strong> human plasma. After a double<br />

extraction of 0.2 or 1.0 mL of plasma conta<strong>in</strong><strong>in</strong>g phenobarbital<br />

as an <strong>in</strong>ternal standard, thiopental and the <strong>in</strong>ternal<br />

standard are derivatized <strong>in</strong> a polar non-aqueous solvent<br />

system with iodomethane. The reaction mixture is then<br />

evaporated, the residue reconstituted with ethyl acetate,<br />

and 20 tL <strong>in</strong>jected <strong>in</strong>to a 3% OV-17 column of a gas<br />

chromatograph equipped with a nitrogen-phosphorus<br />

detector. L<strong>in</strong>earity and reproducibility over the concentration<br />

range 25 tg/L to 10 mg/L <strong>in</strong> plasma are excellent.<br />

The sensitivity and wide range of l<strong>in</strong>earity exhibited by this<br />

method permit thorough characterization of the disposition<br />

of thiopental after the usual <strong>in</strong>duction doses of 3-4 mg/kg<br />

of body weight.<br />

Additional Keyphrases: barbiturates . drug assay<br />

anesthetics<br />

<strong>Thiopental</strong> [5-ethyl-5’-( 1 -methylbutyl) -2-thiobarbituric<br />

acidj is an ultra-short-act<strong>in</strong>g barbiturate used to <strong>in</strong>duce anesthesia<br />

<strong>in</strong> man and animals. Numerous methods of analysis<br />

<strong>for</strong> thiopental have been reported <strong>in</strong> the literature. Most lack<br />

the necessary specificity or sensitivity, or both, <strong>for</strong> completely<br />

describ<strong>in</strong>g the disposition k<strong>in</strong>etics of the drug <strong>in</strong> humans.<br />

Oroszlan and Maengwyn-Davies (1) ‘reported a nonspecific<br />

spectrophotometric assay <strong>in</strong>volv<strong>in</strong>g three different wavelengths<br />

and hav<strong>in</strong>g a sensitivity of 1 mg/L. A specific spectrophotofluorometric<br />

method (2) has a reported sensitivity<br />

of 0.1 mg/L and requires 3 mL of plasma. Several “high-per<strong>for</strong>mance”<br />

liquid-chromatographic assays <strong>for</strong> thiopental <strong>in</strong><br />

plasma have also been reported (3, 4). The sensitivity of these<br />

assays ranges between 0.1 and 1.0 mg/L. Numerous gas-liquid-chromatographic<br />

(GLC) procedures <strong>for</strong> barbiturates other<br />

than thiopental have been reported (5-9). A GLC method (10)<br />

with use of a flame ionization detector has a reported sensitivity<br />

of 0.2 mg/L, but we found it to be nonspecific <strong>for</strong> thiopental,<br />

ow<strong>in</strong>g to thepresence of an <strong>in</strong>terfer<strong>in</strong>g peak from the<br />

methylated oxy analog and metabolite of thiopental (pentobarbital).<br />

A specific and apparently sensitive assay was reported<br />

by Van Hamme and Ghoneim (11) to have a “low-end<br />

sensitivity” of


nobarbital per liter). The contents of the tube were vortexmixed<br />

<strong>for</strong> 15 s and centrifuged (3000 rpm, 5 mm). The organic<br />

(upper) phase was then transferred to a 15-mL test tube<br />

conta<strong>in</strong><strong>in</strong>g 1 mL of 2.5 mol/L NaOH. The solution was vortex-mixed<br />

<strong>for</strong> lOs, and centrifuged (3000 rpm, 1 mm), and the<br />

hexane layer aspirated. To the basic aqueous extract was<br />

added 4 mL of drug-free hexane and the solution was vortex-mixed,<br />

centrifuged, and aspirated as be<strong>for</strong>e. To the<br />

washed basic aqueous extract we added 1 mL of 3 molfL HCI<br />

and 4 mL of hexane. The contents of the tube were vortexmixed<br />

and centrifuged as be<strong>for</strong>e, and the organic layer was<br />

separated and evaporated under a stream of nitrogen at 60#{176}C<br />

<strong>in</strong> a Reacti-vial (Pierce Chemical Co., Rock<strong>for</strong>d, IL 61105).<br />

Methylation was per<strong>for</strong>med by add<strong>in</strong>g 500 zL of acetone,<br />

100 L of iodomethane, and about 5 mg of sodium carbonate<br />

to the dried hexane extract, then <strong>in</strong>cubat<strong>in</strong>g the mixture <strong>in</strong><br />

a vortex evaporator at 60 #{176}C <strong>for</strong> 30 mm. The supernate then<br />

was evaporated as be<strong>for</strong>e and reconstituted <strong>in</strong>to 20 L of ethyl<br />

acetate by vortex-mix<strong>in</strong>g; 2 tL was <strong>in</strong>jected <strong>in</strong>to the gaschromatographic<br />

column. Retention times <strong>for</strong> thiopental and<br />

phenoharbital are 1.7 and 1.3 mm, respectively. The standard<br />

curves were constructed by plott<strong>in</strong>g thiopental/phenobarbital<br />

peak height ratios vs thiopental concentrations.<br />

For standard curves <strong>for</strong> higher thiopental concentrations,<br />

200 L of plasma conta<strong>in</strong><strong>in</strong>g 0, 0.5, 1, 2.5, 5, and 10 mg of<br />

thiopental per liter was added to 200 tL of 1.5 mol/L NaH2-<br />

P04 and 200 zL of 2-propanol, and the mixture was extracted<br />

with 1 mL of hexane conta<strong>in</strong><strong>in</strong>g 8 mg of phenobarbital per<br />

liter. The extraction procedure at these higher plasma thiopental<br />

concentrations was per<strong>for</strong>med as <strong>for</strong> the lower concentrations,<br />

except that the basic aqueous extract was not<br />

washed with hexane. Methylation was done as be<strong>for</strong>e.<br />

Analytical<br />

Variables<br />

Reproducibility. The reproducibility of the method was<br />

determ<strong>in</strong>ed from results <strong>for</strong> repeated <strong>in</strong>jections. Concentrations<br />

of 50 and 500 g/L <strong>in</strong> plasma <strong>for</strong> the low-end standard<br />

curve and 1 and 10 mgfL <strong>for</strong> the high-end standard curve were<br />

prepared and each solution was <strong>in</strong>jected six times <strong>in</strong>to the<br />

chromatograph.<br />

Extraction efficiency. We determ<strong>in</strong>ed the efficiency of the<br />

extraction of thiopental from plasma by add<strong>in</strong>g known<br />

amounts of thiopental, equivalent to concentrations of 50 and<br />

500 g/L <strong>in</strong> plasma, to the hexane layers after extraction of<br />

drug-free plasma as previously described. The concentrations<br />

of thiopental <strong>in</strong> these samples were compared with the same<br />

concentrations of thiopental that had been added directly to<br />

plasma and extracted as previously described.<br />

Stability. Concentrations of 50 and 500 ig of thiopental per<br />

liter were prepared as described above, each <strong>in</strong> 10 mL of<br />

plasma. One-milliliter or 200-tL samples from each concentration<br />

were placed <strong>in</strong>to separate glass tubes and stored at -20<br />

#{176}C. Analyses were per<strong>for</strong>med once a week <strong>for</strong> eight weeks. On<br />

each day of analysis a standard curve <strong>in</strong> plasma was constructed<br />

and the thiopental concentrations of the stored<br />

samples were determ<strong>in</strong>ed by compar<strong>in</strong>g their thiopental/<br />

phenobarbital peak height ratios with those of the standard<br />

curve.<br />

Data<br />

Analysis<br />

With all standard curves, a straight-l<strong>in</strong>e fit of the data was<br />

per<strong>for</strong>med by least-squares l<strong>in</strong>ear regression analysis. All results<br />

are expressed as mean ± standard deviation (SD).<br />

Results and Discussion<br />

The use of a nitrogen-specific detector <strong>in</strong> analyses <strong>for</strong> barbiturates<br />

has been described by many workers. Such studies<br />

show that these compounds are not readily gas-chromatographed<br />

without prior derivatization, especially when nano-<br />

lS<br />

I IS I<br />

T<br />

HH1HI<br />

I I , I r I I , , I<br />

2 1 02 1 0 2 1 021 0<br />

A<br />

B<br />

C 0<br />

Fig. 1. <strong>Gas</strong>-chromatographictrac<strong>in</strong>gsobta<strong>in</strong>ed<strong>for</strong> human<br />

plasma<br />

A: Extractof1 mL ofdrug-free plasma with phenobarbital (IS) as <strong>in</strong>ternal Standard.<br />

B: Extractof 1 mL of plasma with 50 ig of thiopental (T) added perliter.<br />

C: Extract of 200 zL of drug-free plasma with phenobarbital (IS). D: Extract of<br />

200 iL of plasma supplemented with 500 .sg of thiopental (7) per liter<br />

gram amounts are <strong>in</strong>jected <strong>in</strong>to the columns. In addition,<br />

chromatography of the free drug does not take full advantage<br />

of the sensitivity of a nitrogen-phosphorus detector. When<br />

barbiturates are methylated by flash-heater methylat<strong>in</strong>g<br />

techniques with trimethylanil<strong>in</strong>ium hydroxide or tetramethylammonium<br />

hydroxide, the nitrogen detector detects<br />

large peaks <strong>in</strong> the chromatogram, caused by the derivatiz<strong>in</strong>g<br />

agents at the sensitivities required <strong>for</strong> the analysis. Dunges<br />

and Bergheim-Irps (13) reported a method <strong>in</strong> which an alkyl<br />

iodide and sodium carbonate <strong>in</strong> a polar nonaqueous solvent<br />

system were used to prepare the alkyl derivative. This procedure<br />

allowed better control of reaction conditions and<br />

avoided pyrolytic <strong>for</strong>mation of trialkylam<strong>in</strong>es, thus permitt<strong>in</strong>g<br />

measurement of thiopental concentrations <strong>in</strong> the microgram<br />

per liter range.<br />

Figure 1 depicts representative chromatograms <strong>for</strong> the high<br />

(500 g/L) and low (50 tg/L) concentrations. The methylated<br />

oxy analog of thiopental, N,N-dimethylpentoharbital, elutes<br />

with the solvent front <strong>in</strong> our system.<br />

The standard curves constructed <strong>for</strong> the peak height ratios<br />

of thiopental to <strong>in</strong>ternal standard were all l<strong>in</strong>ear and reproducible.<br />

Seven standard curves <strong>for</strong> thiopental <strong>in</strong> plasma with<br />

concentrations of 0, 25, 50, 100, 250, and 500 g/L at the low<br />

concentrations and 0, 0.5, 1, 2.5, 5, and 10 mg/L at the high<br />

concentrations were made at different times dur<strong>in</strong>g two weeks.<br />

The slopes of the plot of peak height ratio of thiopental to<br />

<strong>in</strong>ternal standard vs thiopental concentration <strong>in</strong> plasma <strong>for</strong><br />

the 42 po<strong>in</strong>ts at the low and high concentrations were 0.00585<br />

± 0.00021 L/g and 0.523 ± 0.013 L/mg, respectively. The<br />

coefficients of variation (CV) of the slopes were 3.6 and 2.5%,<br />

Is<br />

T<br />

IS<br />

114 CLINICAL CHEMISTRY, Vol. 27, No. 1, 1981


20<br />

I0<br />

5.<br />

11.I0.5<br />

here is necessary to characterize completelythe pharmacok<strong>in</strong>etics<br />

of thiopental after the usual 3-4 mg/kg <strong>in</strong>duction<br />

doses. An illustration of the latter application is shown <strong>in</strong><br />

Figure 2, a plot of thiopental serum concentrations as a<br />

function of time after the <strong>in</strong>travenous adm<strong>in</strong>istration of a 4.8<br />

mg/kg dose of thiopental sodium to one subject. The assay<br />

sensitivity permitted characterization of the concentrationtime<br />

course <strong>for</strong> two days; the data were best described by a<br />

triexponential function with a term<strong>in</strong>al elim<strong>in</strong>ation half-life<br />

of 8.6 h.<br />

Supported <strong>in</strong> part by a grant from the Office of the Provost <strong>for</strong><br />

Graduate Studies and Health Sciences, University of Arizona.<br />

0.1<br />

0.05<br />

N<br />

N,<br />

) 10 20 30 40 50<br />

Time,h<br />

Fig. 2. <strong>Thiopental</strong> concentration <strong>in</strong> serum as a function of time<br />

<strong>in</strong> a subject who received an <strong>in</strong>travenous thiopental sodium dose<br />

of 4.8 mg/kg.<br />

The solid l<strong>in</strong>e represents<br />

a non-l<strong>in</strong>earregression fit of the data<br />

and correlation coefficients of 0.98 and 0.99 were obta<strong>in</strong>ed <strong>for</strong><br />

the low-end and high-end standard curves, respectively. The<br />

correspond<strong>in</strong>g <strong>in</strong>tercepts were -0.090 (SD 0.049) tg/L and<br />

-0.168 (SD 0.062) mg/L.<br />

The CVs <strong>for</strong> thiopental <strong>in</strong> plasma <strong>for</strong> the low-end standard<br />

curve were 6.0% (51.7 ± 3.1 tg/L) and 3.9% (507.1 ± 19.8<br />

tg/L), respectively. At the high concentrations, the coefficients<br />

of variation <strong>for</strong> thiopental were 10.5% (1.05 ± 0.11<br />

mg/L) and 3.4% (10.14 ± 0.34 mg/L), respectively.<br />

Analytical recovery of thiopental from plasma averaged 89.9<br />

(SD 6.6)% and 82.8 (SD 2.2)% at 50 and 500 sg/L, respectively.<br />

No detectable deterioration <strong>in</strong> thiopental was observed over<br />

an eight-week study period. The 50 and 500 g/L solutions<br />

yielded concentrations of 49.9 (SD 4.6) tg/L and 497.5 (SD<br />

29.2) zg/L, respectively.<br />

Diazepam, fentanyl, and morph<strong>in</strong>e-drugs frequently used<br />

<strong>in</strong> conjunction with thiopental-were tested <strong>for</strong> potential<br />

<strong>in</strong>terference with the thiopental assay. These drugs are bases<br />

and are not extracted <strong>in</strong> our procedure, so, as expected, we saw<br />

no <strong>in</strong>terfer<strong>in</strong>g peaks at the retention times of thiopental or its<br />

<strong>in</strong>ternal standard, phenobarbital.<br />

Our method is more sensitive and specific than other published<br />

methods. The 25 tg/L sensitivity of the assay described<br />

References<br />

I. Oroszlan, S. I., and Maengwyn-Davies, G. D., Ultraviolet photometric<br />

assay of thiopental and pentobarbital <strong>in</strong> blood and plasma. J.<br />

Am. Pharm. Assoc., Sci. Ed. 49,507-509(1960).<br />

2. Dayton, P. G., Perel, J. M., Landrau, M. A., et al., The relationship<br />

between b<strong>in</strong>d<strong>in</strong>g of thiopental to plasma and its distribution <strong>in</strong>to<br />

adipose tissue <strong>in</strong> man, as measured by a spectrophotofluorimetric<br />

method. Riochem. Pharmacol. 16, 2321-2336 (1967).<br />

3. Blackman, C. L., and Jordan, C. J., Analysis of thiopentone <strong>in</strong><br />

plasma by high-per<strong>for</strong>mance liquidchromatography. J. Chromatogr.<br />

145, 492-495 (1978).<br />

4. Masoud, A. N., Scratchley,G. A., Stohs, S. J., and W<strong>in</strong>gard, D. W.,<br />

Simultaneous determ<strong>in</strong>ation of lidoca<strong>in</strong>e (lignoca<strong>in</strong>e) and thiopental<br />

<strong>in</strong> plasma us<strong>in</strong>g high pressure liquid chromatography. J. Liq. Chromat<br />

ogr. 1,607-616 (1978).<br />

5. Braddock, L. I., and Marec, N., <strong>Gas</strong> chromatographic analysis of<br />

submicrogram quantities of barbiturates us<strong>in</strong>g a flame ionization<br />

detector. J. <strong>Gas</strong> Chromatogr. 3,274-277 (1965).<br />

Ii. l)unges, W., Bergheim-Irps, E., Straub, H., and Kaiser, R. E.,<br />

Microtechniques <strong>for</strong> the gas chromatographic determ<strong>in</strong>ation of barbiturates<br />

<strong>in</strong> small blood samples. J. Chromatogr. l45, 265-274<br />

(1978).<br />

7. Greely, R. H., New approach to derivatization and gas-chromatographic<br />

analysis of barbiturates. (‘un. Chem. 20, 192-194 (1974).<br />

8. MacGee, J., Rapid identification and quantitative determ<strong>in</strong>ation<br />

of barbiturates and glutethimide <strong>in</strong> blood by gas-liquid chromatography.<br />

(‘ha. (‘hem. 17, 587-591 (1971).<br />

9. Fiereck, E. A., and Tietz, N. W., A gas-chromatographic method<br />

b>r separat<strong>in</strong>g and measur<strong>in</strong>g barbiturates and glutethimide <strong>in</strong> blood.<br />

(‘un. (‘hem. l7, 1024-1027 (1971).<br />

10. Becker, K. E., Jr., <strong>Gas</strong> chromatographic assay <strong>for</strong> free and total<br />

plasma levels of thiopental. Anesthesiology 45, 656-660 (1976).<br />

II. Van Hamme, M. J., and Ghoneim, M. M ., A sensitive gas chromatographic<br />

assay <strong>for</strong> thiopentone <strong>in</strong> plasma. Br. J. Anaesth. .50,<br />

143-145 (1978).<br />

12. Sennello,L. T., and Kohn, F. B., <strong>Gas</strong> chromatographic determ<strong>in</strong>ation<br />

of thiopental <strong>in</strong> plasma us<strong>in</strong>g an alkali flame ionization detector.<br />

Anal. Chem. 46, 752-755 (1974).<br />

13. Dunges, W., and Bergheim-Irps, E., A new methylation method<br />

<strong>for</strong> the gas chromatography of barbituric acids. Anal. Lett. 6, 185-195<br />

41973).<br />

CLINICALCHEMISTRY, Vol.27,No. 1,1981 115

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!